Diuretics and β-Blockers Do Not Have Adverse Effects at 1 Year on Plasma Lipid and Lipoprotein Profiles in Men With Hypertension
Author(s) -
M Lakshman
Publication year - 1999
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.159.6.551
Subject(s) - hydrochlorothiazide , placebo , medicine , atenolol , endocrinology , adverse effect , carvedilol , chlorthalidone , apolipoprotein b , lipoprotein , irbesartan , prazosin , cholesterol , pharmacology , diuretic , blood pressure , antagonist , heart failure , alternative medicine , receptor , pathology
Concern based on the reported short-term adverse effects of antihypertensive agents on plasma lipid and lipoprotein profiles (PLPPs) has complicated the therapy for hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom